Autoinflammatory Disease Symposium
Please stay tuned for announcements on future symposia.
Previous Symposium:
29 August 2022
Walter and Eliza Hall Institute of Medical Research
ALL DELEGATES HAVE BEEN EMAILED A LINK TO VIEW A RECORDING OF THE SYMPOSIUM.
If you did not receive the link, or have any other queries, please email AIDsymposium@wehi.edu.au
Plenary speakers:
Professor Marco Gattorno
President of the International Society of Autoinflammatory Diseases, and Head of Printo (Italy)
Dr Ivona Aksentijevich
Inflammatory Disease Section/Clinical Genetics Service, NHGRI, NIH, (USA)
9-10.30 Science session 1: The molecular basis of autoinflammation
Prof Kate Schroder (University of Queensland, Science overview, NLRP3 inhibitor update) 10
Dr Najoua Laloui (Peter MacCallum Cancer Centre, Autoinflammation due to cleavage resistant RIPK1) 20+5
Dr Ivona Aksentijevich (National Institutes of Health USA, Ubiquitination and Autoinflammation) 25+5
Dr Marcia Munoz (Garvan Institute, Prenylation in Mevalonate Kinase Deficiency) 20+5
Morning Tea
11-12.30 Science session 2: The molecular basis of autoinflammation
Prof Shane Grey (Garvan Institute, Haploinsufficiency of A20) 25+5
Dr Elisabeth Mulazzani (WEHI, Blockade of G-CSF for APLAID) 10+5
Dr Joanne Hildebrand (WEHI, MLKL and inflammatory disease) 10+5
Dr Annemarie Steiner (WEHI, Sting activation in COPA syndrome) 10+5
Dr Sophia Davidson (WEHI, Dominant negative Otulin deficiency) 10+5
Lunch
1.30-3 Clinical session 1: Treatment and therapy of AID
Dr Ed Giles (Monash University, Advances in diagnosis and therapy of EOIBD) 25+5
Dr Rohit Saldanha (Sydney Children’s Hospital, JAK inhibition for interferonopathies) 25+5
Dr Samar Ojaimi (Monash Health) and Thomas Reygaerts (WEHI, CDC42 AID) 15+5
Dr Shruti Swamy (Sydney Children’s Hospital, Case report of ADA2 deficiency) 8+2
Afternoon tea
3.30-5 Clinical session 2: Treatment and therapy of AID
Dr Peter McNaughton (Queensland Children’s Hospital, diagnosis of AID) 15+5
Dr Sam Mehr (Royal Children’s Hospital, targeting biological therapy for AID) 15+5
Dr Marco Gattorno (Gaslini Institute, AID diagnosis and therapy overview) 25+5
Karen Raymond (Adelaide, Personal take on life with, and research of, CAPS) 10+5
5-6 Patient Session: Panel Discussion
Nicole Millis (RareVoices Australia) 10
Sharon Kensell (FMF & AID Australia) 5
Panel Discussion 45
Dr Marco Gattorno (Gaslini Institute Italy, Pediatric Rheumatology)
Dr Melanie Wong (Children’s Hospital at Westmead, Pediatric Immunology)
Dr Charlotte Slade (Melbourne Health, Clinical Immunology)
Dr Michael O’Sullivan (Fiona Stanley Hospital, Clinical Immunology)
Post event refreshments
Satellite conference to:
ASCIA 2022, 30 August - 2 September
Annual conference of the Australasian Society of Clinical Immunology and Allergy